Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 1-2, 1996, Pages 90-96

  Olivi, Alessandro ^a   Ewend, Matthew G ^a   Utsuki, Tadanobu ^a   Tyler, Betty ^a   Domb, Abraham J ^b   Brat, Daniel J ^a   Brem, Henry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Brain tumor; Carboplatin; Drug delivery systems; Glioma; Polymer

Indexed keywords

CARBOPLATIN; COPOLYMER; POLYMER;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; GLIOMA; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED RELEASE PREPARATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARBOPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; GLIOMA; MALE; NEOPLASMS, EXPERIMENTAL; POLYMERS; RATS; RATS, INBRED F344;

EID: 0029849099     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050542     Document Type: Article

References (42)

1. Brem H, Mahaley MJ, Vick NA, Black KL, Schold SJ, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy J (1991) Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441
2. Brem H, Domb A, Lenartz D, Dureza C, Olivi A, Epstein JI (1992) Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid. J Controlled Release 19:325
3. Brem H, Tamargo RJ, Olivi A, Finn M, Weingart JD, Wharam M, Epstein JI (1994) Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J Neurosurg 80:283
4. Brem H, Ewend M, Piantadosi S, Burger P, Greenhoot J, Sisti M (1995) The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J Neurooncol 26:111
5. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC and Polymer Brain Tumor Therapy Group (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008
6. Charrow J, Listernick R, Greenwald MJ, Das L, Radkowski MA (1993) Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis. Med Pediatr Oncol 21:680
7. Chasin M, Lewis D, Langer R (1988) Polyanhydrides for controlled drug delivery. Biopharm Manufact 1:33
8. Comis RL (1993) Carboplatin in the treatment of non-small cell lung cancer: a review. Oncology 2:37
9. Domb A, Bogdansky S, Olivi A, Judy K, Dureza C, Lenartz M, Pinn M, Colvin O, Brem H (1991) Controlled delivery of water soluble and hydrolytically unstable anticancer drugs from polymeric implants. Polymer Preprints 32:219
10. Doz F, Berens ME, Dougherty DV, Rosenblum ML (1991) Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures. J Neurooncol 11:27
11. Dropcho EJ, Rosenfeld SS, Morawetz RB, Vitek J, Brothers M, Gorum T, Bell S, Gillespie GY, Glantz M, Mahaley M Jr (1992) Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium. J Clin Oncol 10:452
12. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585
13. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DHJ, Whitehead MV, Kun LE (1992) Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 10:249
14. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD (1990) Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Cancer 66:2465
15. Goodman JH, McGregor JM, Clendenon NR, Gahbauer RA, Barth RF, Soloway AH, Fairchild RG (1990) Inhibition of tumor growth in a glioma model treated with boron neutron capture therapy. Neurosurgery 27:383
16. Hannigan E, Green S, Alberts D, O'Toole R, Surwit E (1993) Results of a Southwest Oncology Group Phase II Trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer. Oncology 50 [suppl 2]:2
17. Hoff von D, Schilaky R, Reickert C, Reddiek R, Rozencweig M, Young R, Muggia F (1979) Toxic effects of cis-dichlorodiammine platinum (II) in man. Cancer Treat Rep 63:1527
18. Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10:520
19. Jones AL, Holborn J, Ashley S, Smith IE (1993) CVM versus ACE in the treatment of small cell lung cancer. Oncology 2:10
20. Judy K, Olivi A, Buahin K, Domb A, Epstein J, Colvin O, Brem H (1995) Controlled release of a cyclophosphamide derivative with polymers is effective against rat gliomas. J Neurosurg 82:103
21. Kaplan EL, Meier P, (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457
22. Ko L, Koestner A, Wechsler W (1980) Characterization of cell cycle and biological parameters of transplantable glioma cell lines and clones. Acta Neuropathol 51:107
23. Ko L, Koestner A, Wechsler W (1980) Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol 51:23
24. Kornblith PL, Walker M (1988) Chemotherapy for malignant gliomas. J Neurosurg 68:1
25. Kroin JS, Penn RD (1982) Intracerebral chemotherapy: chronic microinfusion of cisplatin. Neurosurgery 10:349
26. Mahaley M, Hipp S, Dropcho E, Bertsch L, Cush S, Tirey T, Gillespie G (1989) Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 70:371
27. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719
28. Mottet-Auselo N, Bons-Rosset F, Costa P, Louis JF, Navratil H (1993) Carboplatin and urothelial tumors. Oncology 2:28
29. O'Brien ME, Tonge K, Blake P, Moskovic E, Wiltshaw E (1992) Blindness associated with high-dose carboplatin. Lancet 339:558
30. O'Brien ME, Talbot DC, Smith IE (1993) Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule. J Clin Oncol 11:2112
31. Olivi A, Gilbert M, Duncan KL, Corden B, Lenartz D, Brem H (1993) Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study. Cancer Chemother Pharmacol 31:449
32. Pico JL, Ibrahim A, Castagna L, Bourhis JH, Chazard M, Maraninchi D, Droz JP (1993) Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors. Oncology 2:47
33. Poisson M, Pereon Y, Chiras J, Delattre JY (1991) Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA). J Neurooncol 10:139
34. Schnabel T, Zamboglou N, Kolotas C, Hartmann A, Schmitt G (1993) Combined radiochemotherapy with carboplatin in the treatment of advanced head and neck carcinomas. Oncology 2:16
35. Shapiro WR, Shapiro JR (1986) Principles of brain tumor chemotherapy. Semin Oncol 13:56
36. Shikani A, Eisele D, Domb A (1994) Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck. Arch of Otolaryngol, Head Neck Surg 120:1242
37. Stewart DJ, Belanger JM, Grahovac Z, Curuvija S, Gionet LR, Aitken SE, Hugenholtz H, Benoit BG, DaSilva VF (1992) Phase I study of intracarotid administration of carboplatin. Neurosurgery 30:512
38. Twelves CJ, Ash CM, Miles DW, Thomas DG, Souhami RL (1991) Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma. Cancer Chemother Pharmacol 27:481
39. Walker MD, Green SB, Byar DP, Alexander EJ, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MJ, Mealey JJ, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KJ, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323
40. Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H (1995) Intratumoral Chemotherapy. Neurosurgery 37:1129
41. Williams PC, Henner WD, Roman-Goldstein S, Dahlborg SA, Brummett RE, Tableman M, Dana BW, Neuwelt EA (1995) Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery 37:17
42. Zeltzer PM, Epport K, Nelson MJ, Huff K, Gaynon P (1991) Prolonged response to carboplatin in an infant with brain stem glioma. Cancer 67:43